BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats

Kidney International

Volumn 67, Issue 5, 2005, Pages 1855-1867

  Kazama, Itsuro ^b   Hatano, Ryo ^b   Michimata, Mari ^b   Suzuki, Katsuya ^b   Arata, Tomohiro ^b   Suzuki, Michiko ^b   Miyama, Noriyuki ^b   Sato, Akira ^b   Satomi, Susumu ^b   Ejima, Yutaka ^b   Sasaki, Sei ^b   Matsubara, Mitsunobu ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Arginine vasopressin; Combination therapy; Furosemide; OPC 31260

Indexed keywords

AQUAPORIN 2; ARGIPRESSIN; DESMOPRESSIN; FUROSEMIDE; LOOP DIURETIC AGENT; MOZAVAPTAN; VASOPRESSIN V2 RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; KIDNEY MEDULLA; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM BLOOD LEVEL; WATER LOADING; WESTERN BLOTTING;

EID: 20244371679     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00284.x     Document Type: Article

References (41)

1. ANDERSON RJ, CHUNG H, KLUGE R, SCHRIER RW: Hyponatremia: A prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 102:164-168, 1985
2. GROSS P, REIMANN D, NEIDEL J, et al: The treatment of severe hyponatremia. Kidney Int (Suppl 64):S6-11, 1988
3. ZERBE R, STROPEZ L, ROBERTSON G.: Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 31:315-327, 1980
4. BARTTER FC, SCHWARTZ WB: The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 42:790-806, 1967
5. SAITO T, HIGASHIYAMA M, NAGASAKA S, et al: Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis. Kidney Int 60:1266-1276, 2001
6. ECELBARGER CA, NIELSEN S, OLSON BR, et al: Role of renal aquaporins in escape from vasopressin-induced antidiuresis in rat. J Clin Invest 99:1852-1863, 1977
7. FUJITA N, ISHIKAWA S, SASAKI S, et al: Role of water channel AQP-CD in water retention in SIADH and cirrhotic rats. Am J Physiol 269:F926-931, 1995
8. HOZAWA S, HOLTZMAN EJ, AUSIELLO DA: cAMP motifs regulating transcription in the aquaporin 2 gene. Am J Physiol 270:C1695-1702, 1996
9. JAMISON RL, MAFFLY RH: The urinary concentrating mechanism. N Engl J Med 295:1059-1067, 1976
10. +:2Cl- cotransporter and the thick ascending limb. Kidney Int 36:418-426, 1989
11. 2 receptor in rat kidney. J Clin Invest 94:1778-1783, 1994
12. YAMAMOTO T, SASAKI S, FUSHIMI K, et al: Vasopressin increases AQP-CD water channel in apical membrane of collecting duct cells in Brattleboro rats. Am J Physiol 269:C655-C664, 1995
13. SHYAYAKUL C, SMITH CP, MACKENZIE HS, et al: Long-term regulation of urea transporter expression by vasopressin in Brattleboro rats. Am J Physiol 278:F620-F627, 2000
14. MICHIMATA M, NOGAE S, OHTA M, et al: Topographic distribution of aquaporin 2 mRNA in the kidney of dehydrated rats. Exp Nephrol 8:28-36, 2000
15. MARUMO R., KAIZUMA S, NOGAE S, et al: Differential upregulation of rat Na-K-Cl cotransporter, rBSC1, mRNA in the thick ascending limb of Henle in different pathophysiological conditions. Kidney Int 54:877-888, 1998
16. MICHIMATA M, WANG W, FUJITA S, et al: Limited urinary concentration and damaged tubules in rats with a syngeneic kidney graft. Kidney Int 60:672-679, 2001
17. MICHIMATA M, MIZUKAMI H, KAZAMA I, et al: Vasopressin independent urinary concentration: Increased rBSC1 expression and enhanced countercurrent multiplier. Kidney Int 64:933-938, 2003
18. VERBALIS JG: An experimental model of syndrome of inappropriate antidiuretic hormone secretion in the rat. Am J Physiol 247:E540-553, 1984
19. ROBERTSON GL, AYCINEMA P, ZERBE RL: Neurogenic disorders of osmoregulation. Am J Med 72:339-353, 1982
20. DE TROYER A: Demeclocycline: Treatment for syndrome of inappropriate antidiuretic hormone secretion. JAMA 237:2723-2726, 1977
21. COGAN E, ABRAMOW M: Inhibition by lithium of the hydroosmotic action of vasopressin in the isolated perfused cortical collecting tubule of the rabbit. J Clin Invest 77:1507-1514, 1986
22. FORREST JN, COX M, HONG C, et al: Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 298:173-177, 1978
23. MILLER PD, LINAS SL, SCHRIER RW: Plasma demeclocycline levels and nephrotoxicity: Correlation in hyponatremic cirrhotic patients. JAMA 243:2513-2515, 1980
24. MANING M, SAWYER WH: Discovery, development, and some uses of vasopressin and oxytocin antagonists. J Lab Clin Med 114:617-632, 1989
25. 2 receptor antagonist. Br J Pharmacol 105:787-791, 1992
26. OHNISHI A, ORITA Y, OKAHARA R, et al: Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men. J Clin Invest 92:2653-2659, 1993
27. SAITO T, ISHIKAWA S, ABE K, et al: Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Clin Endocrinol Metab 82:1054-1057, 1997
28. DECAUX G.: Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by long loop diuretics. Nephron 35:82-88, 1983
29. FUJISAWA G, ISHIKAWA S, TSUBOI Y, et al: Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats. Kidney Int 44:19-23, 1993
30. MICHIMATA M, FUJITA S, ARAKI T, et al: Reverse pharmacological effect of loop diuretics and altered rBSC1 expression in rats with lithium nephropathy. Kidney Int 63:165-171, 2003
31. MICHIMATA M, KAZAMA I, MIZUKAMI K, et al: Urinary concentration defect and limited expression of sodium cotransporter, rBSC1, in a rat model of chronic renal failure. Nephron Physiol 93:34-41, 2003
32. FERNANDEZ-LLAMA P, ECELBARGER CA, WARE JA, et al: Cyclooxygenase inhibitors increase Na-K-2Cl cotransporter abundance in thick ascending limb of Henle's loop. Am J Physiol 277:F219-226, 1999
33. ATTMANE-ELAKEB A, SIBELLA V, VERNIMMEN C, et al: Regulation by glucocorticoids of expression and activity of rBSC1, the Na+-K+-2Cl- cotransporter of medullary thick ascending limb. J Biol Chem 275:33548-33553, 2000
34. NOGAE S, MICHIMATA M, KANAZAWA M, et al: Cardiac infarcts increase sodium transporter transcripts (rBSC1) in the thick ascending limb of Henle. Kidney Int 57:2055-2063, 2000
35. JONASSEN TE, BROND L, TORP M, et al: Effects of renal denervation on tubular sodium handling in rats with CBL-induced liver cirrhosis. Am J Physiol Renal Physiol 284:F555-563, 2003
36. CHAN WY: A study of the mechanism of vasopressin escape: Effects of chronic vasopressin and overhydration on renal tissue osmolality and electrolytes in dogs. J Pharmacol Exp Ther 184:244-252, 1973
37. AYUS JC, KROTHAPALLI RK, ARMSTRONG DL: Rapid correction of severe hyponatremia in the rat: Histopathological changes in the brain. Am J Physiol 248:F711-719, 1985
38. 2 receptor antagonist OPC-31260. Nephron 76:111-115, 1997
39. DECAUX G: Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea, or furosemide. Am J Med 110:582-584, 2001
40. SANTON BA, KAISSLING B: Adaptation of distal tubule and collecting duct to increased Na delivery. Na+ and K+ transport. Am J Physiol 255:F1269-F1275, 1988
41. KAISSLING B, SANTON BA: Adaptation of distal tubule and collecting duct to increased Na delivery. Ultrastructure. Am J Physiol 255:F1256-F1268, 1988